Genomics England Selects Cognizant as a Technology Partner for the Department of Health's 100,000 Genomes Project

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. ACN
3. NVDA
4. MU
5. GOOGL
6. APGE
7. DFTX
8. RGNX
9. LCO
10. KR

Go back to Genomics England Selects Cognizant as a Technology Partner for the Department of Health's 100,000 Genomes Project

Cognizant (CTSH) Reports a 3Q Beat and Raise; Needham & Company Reiterates Buy

November 5, 2015 7:18 AM EST

Needham & Company reiterated a Buy rating and $78.00 price target on Cognizant Technology Solutions (NASDAQ: CTSH) following the company's 3Q earnings report. Cognizant reported solid 3Q results, with revenue increasing 3.3% Q/Q and 23.5% Y/Y to $3.187 billion, above consensus of $3.167 billion. Management raised the FY15 outlook for the third time this... More